# Diagnostic Agreement of iFR and QFR.

> **NCT03420131** · — · UNKNOWN · sponsor: **Contilia Clinical Research Institute** · enrollment: 250 (estimated)

## Conditions studied

- Fractional Flow Reserve, Myocardial
- Coronary Artery Disease

## Interventions

- **DIAGNOSTIC_TEST:** QFR and iFR

## Key facts

- **NCT ID:** NCT03420131
- **Lead sponsor:** Contilia Clinical Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-18
- **Primary completion:** 2018-07-28
- **Final completion:** 2018-10-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420131, "Diagnostic Agreement of iFR and QFR.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03420131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*